{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:19:05Z","timestamp":1778977145859,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T00:00:00Z","timestamp":1519171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00347-018-0664-6","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T04:17:52Z","timestamp":1519186672000},"page":"489-498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Konjunktivales Melanom","Conjunctival melanoma"],"prefix":"10.1007","volume":"115","author":[{"name":"AG SOP","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan\u2011Peter","family":"Glossmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Unter-AG Konjunktivales Melanom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Skoetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Starbatty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Leyvraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrike","family":"Westekemper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig M.","family":"Heindl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,21]]},"reference":[{"key":"664_CR1","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1016\/j.ophtha.2011.05.025","volume":"118","author":"LM Heindl","year":"2011","unstructured":"Heindl LM, Hofmann-Rummelt C, Adler W et al (2011) Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology 118:2351\u20132360","journal-title":"Ophthalmology"},{"key":"664_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/ICU.0b013e32833b7aab","volume":"21","author":"Y Shildkrot","year":"2010","unstructured":"Shildkrot Y, Wilson MW (2010) Conjunctival melanoma: pitfalls and dilemmas in management. Curr Opin Ophthalmol 21:380\u2013386","journal-title":"Curr Opin Ophthalmol"},{"key":"664_CR3","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s00347-015-0142-3","volume":"112","author":"LM Heindl","year":"2015","unstructured":"Heindl LM, Cursiefen C (2015) Bindehautmelanom \u2013 eine Systemerkrankung: neue chirurgische und adjuvante Therapien. Ophthalmologe 112:890\u2013891","journal-title":"Ophthalmologe"},{"key":"664_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0002-9394(02)02288-2","volume":"135","author":"GP Yu","year":"2003","unstructured":"Yu GP, Hu DN, McCormick S, Finger PT (2003) Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol 135:800\u2013806","journal-title":"Am J Ophthalmol"},{"key":"664_CR5","doi-asserted-by":"publisher","first-page":"7074","DOI":"10.1167\/iovs.11-7902","volume":"52","author":"LM Heindl","year":"2011","unstructured":"Heindl LM, Hofmann-Rummelt C, Adler W et al (2011) Tumor-associated lymphangiogenesis in the development of conjunctival melanoma. Invest Ophthalmol Vis Sci 52:7074\u20137083","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"664_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ophtha.2010.06.021","volume":"118","author":"CL Shields","year":"2011","unstructured":"Shields CL, Markowitz JS, Belinsky I et\u00a0al (2011) Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases. Ophthalmology 118:389\u2013395","journal-title":"Ophthalmology"},{"key":"664_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0039-6257(97)00122-7","volume":"42","author":"S Seregard","year":"1998","unstructured":"Seregard S (1998) Conjunctival melanoma. Surv Ophthalmol 42:321\u2013350","journal-title":"Surv Ophthalmol"},{"key":"664_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1442-9071.2008.01888.x","volume":"36","author":"B Damato","year":"2008","unstructured":"Damato B, Coupland SE (2008) Conjunctival melanoma and melanosis: a\u00a0reappraisal of terminology, classification and staging. Clin Experiment Ophthalmol 36:786\u2013795","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"664_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00347-015-0141-4","volume":"112","author":"LM Heindl","year":"2015","unstructured":"Heindl LM, Koch KR, Schlaak M et\u00a0al (2015) Adjuvante Therapie und interdisziplin\u00e4re Nachsorge des Bindehautmelanoms. Ophthalmologe 112:907\u2013911","journal-title":"Ophthalmologe"},{"key":"664_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/IOP.0b013e3182611670","volume":"28","author":"CL Shields","year":"2012","unstructured":"Shields CL, Kaliki S, Al-Dahmash SA et al (2012) American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes. Ophthal Plast Reconstr Surg 28:313\u2013323","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"664_CR11","volume-title":"AJCC cancer staging manual","author":"AJCC","year":"2017","unstructured":"AJCC (2017) AJCC cancer staging manual, 8.\u00a0Aufl. Springer, Cham","edition":"8"},{"key":"664_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000452473","volume":"3","author":"JM Mor","year":"2017","unstructured":"Mor JM, Heindl LM (2017) Systemic BRAF\/MEK inhibitors as a\u00a0potential treatment option in metastatic conjunctival melanoma. Ocul Oncol Pathol 3:133\u2013141","journal-title":"Ocul Oncol Pathol"},{"key":"664_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1055\/s-0043-107807","volume":"234","author":"JJ Bosch","year":"2017","unstructured":"Bosch JJ, Heindl LM (2017) Neue adjuvante Therapien beim okul\u00e4ren Melanom. Klin Monbl Augenheilkd 234:670\u2013673","journal-title":"Klin Monbl Augenheilkd"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-018-0664-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0664-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0664-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T19:23:52Z","timestamp":1550690632000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-018-0664-6"}},"subtitle":["Standardisiertes Vorgehen in Diagnostik, Therapie und Nachsorge","Standard operating procedures in diagnosis, treatment and follow-up care"],"short-title":[],"issued":{"date-parts":[[2018,2,21]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1007\/s00347-018-0664-6","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,21]]},"assertion":[{"value":"21 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.-P.\u00a0Glossmann, N.\u00a0Skoetz, B.\u00a0Starbatty, M.\u00a0Bischoff, S.\u00a0Leyvraz, H.\u00a0Westekemper, L.M.\u00a0Heindl wie auch s\u00e4mtliche Mitglieder der AG SOP und der Unter-AG Konjunktivales Melanom geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}